Keybanc analyst Justin Patterson maintains Pinterest (NYSE:PINS) with a Overweight and raises the price target from $28 to $32.
Deciphera Pharmaceuticals Presents Long-Term Follow-Up Results From INTRIGUE Phase 3 Clinical Study In Second-Line GIST Patients At The 2024 American Society Of Clinical Oncology Gastrointestinal Cancers Symposium
– Median Overall Survival for QINLOCK® of 35.5 Months Versus 31.5 Months for Sunitinib in the All-Patient Intent-to Treat-Population –– Long-Term Safety Profile Consistent with Primary Analysis Showing Fewer
